Testing effectiveness (Phase 2)UnknownNCT05239832
What this trial is testing
Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity
Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 34